<HashMap><database>biostudies-literature</database><scores/><additional><submitter>De Marco C</submitter><funding>Ministero della Salute</funding><funding>Istituto Europeo di Oncologia</funding><funding>Ministero dell’Istruzione, dell’Università e della Ricerca</funding><pagination>101013</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7846933</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(3)</volume><pubmed_abstract>Copy Number Alterations (CNAs) represent the most common genetic alterations identified in ovarian cancer cells, being responsible for the extensive genomic instability observed in this cancer. Here we report the identification of CNAs in a cohort of Italian patients affected by ovarian cancer performed by SNP-based array. Our analysis allowed the identification of 201 significantly altered chromosomal bands (70 copy number gains; 131 copy number losses). The 3300 genes subjected to CNA identified here were compared to those present in the TCGA dataset. The analysis allowed the identification of 11 genes with increased CN and mRNA expression (PDCD10, EBAG9, NUDCD1, ENY2, CSNK2A1, TBC1D20, ZCCHC3, STARD3, C19orf12, POP4, UQCRFS1). PDCD10 was selected for further studies because of the highe</pubmed_abstract><journal>Translational oncology</journal><pubmed_title>Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer.</pubmed_title><pmcid>PMC7846933</pmcid><funding_grant_id>GR-2018-12368359</funding_grant_id><funding_grant_id>2010W4J4RM_001</funding_grant_id><funding_grant_id>PON01_27082</funding_grant_id><pubmed_authors>Rinaldo N</pubmed_authors><pubmed_authors>Morganella S</pubmed_authors><pubmed_authors>Ciliberto G</pubmed_authors><pubmed_authors>Venturella R</pubmed_authors><pubmed_authors>Zullo F</pubmed_authors><pubmed_authors>Ceccarelli M</pubmed_authors><pubmed_authors>Zuccala V</pubmed_authors><pubmed_authors>De Marco C</pubmed_authors><pubmed_authors>Malzoni C</pubmed_authors><pubmed_authors>Malanga D</pubmed_authors><pubmed_authors>Rizzuto A</pubmed_authors><pubmed_authors>Di Vizio D</pubmed_authors><pubmed_authors>Bruni P</pubmed_authors><pubmed_authors>Viglietto G</pubmed_authors><pubmed_authors>Morello M</pubmed_authors><pubmed_authors>Carriero MV</pubmed_authors><pubmed_authors>Zoppoli P</pubmed_authors><pubmed_authors>Chirillo R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genome-wide analysis of copy number alterations led to the characterisation of PDCD10 as oncogene in ovarian cancer.</name><description>Copy Number Alterations (CNAs) represent the most common genetic alterations identified in ovarian cancer cells, being responsible for the extensive genomic instability observed in this cancer. Here we report the identification of CNAs in a cohort of Italian patients affected by ovarian cancer performed by SNP-based array. Our analysis allowed the identification of 201 significantly altered chromosomal bands (70 copy number gains; 131 copy number losses). The 3300 genes subjected to CNA identified here were compared to those present in the TCGA dataset. The analysis allowed the identification of 11 genes with increased CN and mRNA expression (PDCD10, EBAG9, NUDCD1, ENY2, CSNK2A1, TBC1D20, ZCCHC3, STARD3, C19orf12, POP4, UQCRFS1). PDCD10 was selected for further studies because of the highe</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-04-07T17:55:26.797Z</modification><creation>2021-02-21T09:00:54Z</creation></dates><accession>S-EPMC7846933</accession><cross_references><pubmed>33516089</pubmed><doi>10.1016/j.tranon.2021.101013</doi></cross_references></HashMap>